ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.63% | -94.23% | -58.51% | -44.56% | -18.44% |
| Total Depreciation and Amortization | 211.03% | 71.88% | 144.31% | 59.66% | -13.94% |
| Total Amortization of Deferred Charges | 815.38% | 1,566.67% | -- | -- | 77.27% |
| Total Other Non-Cash Items | -20.94% | 13.64% | 24.61% | 15.10% | 22.90% |
| Change in Net Operating Assets | -3,282.86% | -38.07% | 14.86% | -519.28% | -102.58% |
| Cash from Operations | -63.79% | -174.88% | -29.08% | -871.84% | -160.30% |
| Capital Expenditure | 31.16% | -135.16% | -252.46% | 81.37% | -1,558.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 31.16% | -135.16% | -252.46% | 513.69% | -1,558.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -72.21% | 604.76% | 169.42% | -- |
| Repurchase of Common Stock | -- | 100.00% | -52.72% | -132.14% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -96.87% | -35.46% | 52,775.68% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 606.69% | -121.23% | -35.51% | 683.53% | 70.55% |